BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 32878617)

  • 1. Evaluation of the Cochrane Consumers and Communication Group's systematic review priority-setting project.
    Synnot A; Tong A; Ryan R; Hill S
    Health Res Policy Syst; 2020 Sep; 18(1):98. PubMed ID: 32878617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting, refining and identifying priority Cochrane Reviews in health communication and participation in partnership with consumers and other stakeholders.
    Synnot AJ; Tong A; Bragge P; Lowe D; Nunn JS; O'Sullivan M; Horvat L; Kay D; Ghersi D; McDonald S; Poole N; Bourke N; Lannin NA; Vadasz D; Oliver S; Carey K; Hill SJ
    Health Res Policy Syst; 2019 Apr; 17(1):45. PubMed ID: 31036016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Consumers' and health providers' views and perceptions of partnering to improve health services design, delivery and evaluation: a co-produced qualitative evidence synthesis.
    Merner B; Schonfeld L; Virgona A; Lowe D; Walsh L; Wardrope C; Graham-Wisener L; Xafis V; Colombo C; Refahi N; Bryden P; Chmielewski R; Martin F; Messino NM; Mussared A; Smith L; Biggar S; Gill M; Menzies D; Gaulden CM; Earnshaw L; Arnott L; Poole N; Ryan RE; Hill S
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD013274. PubMed ID: 36917094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research priorities in health communication and participation: international survey of consumers and other stakeholders.
    Synnot A; Bragge P; Lowe D; Nunn JS; O'Sullivan M; Horvat L; Tong A; Kay D; Ghersi D; McDonald S; Poole N; Bourke N; Lannin N; Vadasz D; Oliver S; Carey K; Hill SJ
    BMJ Open; 2018 May; 8(5):e019481. PubMed ID: 29739780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term views on chronic kidney disease research priorities among stakeholders engaged in a priority-setting partnership: A qualitative study.
    Elliott MJ; Sale JEM; Goodarzi Z; Wilhelm L; Laupacis A; Hemmelgarn BR; Straus SE
    Health Expect; 2018 Dec; 21(6):1142-1149. PubMed ID: 30112819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. People with lived experience (PWLE) of depression: describing and reflecting on an explicit patient engagement process within depression research priority setting in Alberta, Canada.
    Breault LJ; Rittenbach K; Hartle K; Babins-Wagner R; de Beaudrap C; Jasaui Y; Ardell E; Purdon SE; Michael A; Sullivan G; Unger ASR; Vandall-Walker L; Necyk B; Krawec K; Manafò E; Mason-Lai P
    Res Involv Engagem; 2018; 4():37. PubMed ID: 30349739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cochrane acute respiratory infections group's stakeholder engagement project identified systematic review priority areas.
    Scott AM; Clark J; Dooley L; Jones A; Jones M; Del Mar C
    J Clin Epidemiol; 2018 Oct; 102():63-68. PubMed ID: 29800690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stakeholder involvement in health research priority setting in low income countries: the case of Zambia.
    Kapiriri L
    Res Involv Engagem; 2018; 4():41. PubMed ID: 30460042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.
    Ryan R; Santesso N; Lowe D; Hill S; Grimshaw J; Prictor M; Kaufman C; Cowie G; Taylor M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD007768. PubMed ID: 24777444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying trial recruitment uncertainties using a James Lind Alliance Priority Setting Partnership - the PRioRiTy (Prioritising Recruitment in Randomised Trials) study.
    Healy P; Galvin S; Williamson PR; Treweek S; Whiting C; Maeso B; Bray C; Brocklehurst P; Moloney MC; Douiri A; Gamble C; Gardner HR; Mitchell D; Stewart D; Jordan J; O'Donnell M; Clarke M; Pavitt SH; Guegan EW; Blatch-Jones A; Smith V; Reay H; Devane D
    Trials; 2018 Mar; 19(1):147. PubMed ID: 29490702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying unanswered questions and setting the agenda for future systematic research in Multiple Sclerosis. A worldwide, multi-stakeholder Priority Setting project.
    Celani MG; Nonino F; Mahan K; Orso M; Ridley B; Baldin E; Bignamini AA; D'Amico R; Cantisani TA; Colombo C; Khan F; Köpke S; Laurson-Doube J; Schvarz C; Young CA; Peryer G; Rosati P; Filippini G
    Mult Scler Relat Disord; 2022 Apr; 60():103688. PubMed ID: 35245817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
    Allen D; Gillen E; Rixson L
    JBI Libr Syst Rev; 2009; 7(3):80-129. PubMed ID: 27820426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying and prioritising systematic review topics with public health stakeholders: A protocol for a modified Delphi study in Switzerland to inform future research agendas.
    Hoekstra D; Mütsch M; Kien C; Gerhardus A; Lhachimi SK
    BMJ Open; 2017 Aug; 7(8):e015500. PubMed ID: 28780546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stakeholder Participation for Legitimate Priority Setting: A Checklist.
    Jansen MPM; Baltussen R; Bærøe K
    Int J Health Policy Manag; 2018 Nov; 7(11):973-976. PubMed ID: 30624870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of reviews on principles, strategies, outcomes and impacts of research partnerships approaches: a first step in synthesising the research partnership literature.
    Hoekstra F; Mrklas KJ; Khan M; McKay RC; Vis-Dunbar M; Sibley KM; Nguyen T; Graham ID; ; Gainforth HL
    Health Res Policy Syst; 2020 May; 18(1):51. PubMed ID: 32450919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What are the most important unanswered research questions in trial retention? A James Lind Alliance Priority Setting Partnership: the PRioRiTy II (Prioritising Retention in Randomised Trials) study.
    Brunsdon D; Biesty L; Brocklehurst P; Brueton V; Devane D; Elliott J; Galvin S; Gamble C; Gardner H; Healy P; Hood K; Jordan J; Lanz D; Maeso B; Roberts A; Skene I; Soulsby I; Stewart D; Torgerson D; Treweek S; Whiting C; Wren S; Worrall A; Gillies K
    Trials; 2019 Oct; 20(1):593. PubMed ID: 31615577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.